Durvalumab therapy following chemoradiation compared with a historical cohort treated with chemoradiation alone in patients with stage III non–small cell lung cancer: A real-world multicentre study-Reference-Cited by-同舟云学术

Durvalumab therapy following chemoradiation compared with a historical cohort treated with chemoradiation alone in patients with stage III non–small cell lung cancer: A real-world multicentre study

Published:2021-01 Issue: Volume:142 Page:83-91
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Desilets Antoine,Blanc-Durand Félix,Lau Sally,Hakozaki Taiki,Kitadai Rui,Malo Julie,Belkaid Wiam,Richard Corentin,Messaoudene Meriem,Cvetkovic Lena,Kazandjian Suzanne^ORCID,Tehfe Mustapha,Florescu Marie,Jao Kevin,Daaboul Nathalie,Owen Scott^ORCID,Shieh Benjamin,Agulnik Jason,Cohen Victor,Charbonneau Chloé,Marcoux Nicolas^ORCID,Blais Normand^ORCID,Leighl Natasha B.,Bradbury Penelope A.,Liu Geoffrey,Shepherd Frances A.,Bahig Houda,Routy Bertrand,Sacher Adrian,Elkrief Arielle^ORCID

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference20 articles.

1. Therapeutic management options for stage III non-small cell lung cancer;Yoon;World J Clin Oncol,2017

2. Concurrent chemoradiotherapy in non-small cell lung cancer;O'Rourke;Cochrane Database Syst Rev,2010

3. Multinational randomized phase III trial with or without consolidation chemotherapy using docetaxel and cisplatin after concurrent chemoradiation in inoperable stage III non–small-cell lung cancer: KCSG-LU05-04;Ahn;J Clin Oncol,2015

4. Durvalumab after chemoradiotherapy in stage III non-small-cell lung cancer;Antonia;N Engl J Med,2017

5. Sequential vs. concurrent chemoradiation for stage III non-small cell lung cancer: randomized phase III trial RTOG 9410;Curran;J Natl Cancer Inst,2011

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Contribution of Enhanced Locoregional Control to Improved Overall Survival with Consolidative Durvalumab after Concurrent Chemoradiotherapy in Locally Advanced Non–Small Cell Lung Cancer: Insights from Real-World Data;Cancer Research and Treatment;2024-07-15

2. Pneumonitis Risk After Chemoradiotherapy With and Without Immunotherapy in Patients With Locally Advanced Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis;International Journal of Radiation Oncology*Biology*Physics;2024-07

3. Impact of Durvalumab on the Duration and Complexity of Corticosteroid Therapy for Pneumonitis After Chemoradiotherapy;Clinical Lung Cancer;2024-07

4. Efficacy and safety of concurrent immune checkpoint inhibitors combined with radiotherapy or chemoradiotherapy for advanced non-small cell lung cancer: A systematic review and single-arm meta-analysis;PLOS ONE;2024-06-12

5. Efficacy of consolidation of immune checkpoint inhibitor after chemoradiation for unresectable, locally advanced PD‑L1 negative non‑small cell lung cancer: A systematic review and meta‑analysis;Oncology Letters;2024-04-03